Literature DB >> 29727898

[Immunosuppressive therapy in dogs and cats. Properties of drugs and their use in various immune-mediated diseases].

Johanna Rieder, Reinhard Mischke.   

Abstract

Veterinarians are regularly faced with the diagnosis and therapy of immune-mediated diseases. More frequently occurring immune-mediated diseases are immune-mediated hemolytic anemia, immunemediated thrombocytopenia and polyarthritis. Glucocorticoids are commonly used as first-line treatment because of their availability, efficacy and rapid action. Nevertheless, some patients do not respond to glucocorticoid therapy alone. Others require a rapid dose reduction because of severe side effects from glucocorticoid treatment. These patients benefit from adjuvant therapies. Ciclosporin preparations are licensed for use in veterinary medicine. The use of azathioprine, mycophenolate mofetil and human immunoglobulin therapy has also been documented. This article describes the mode of action of certain immunosuppressive agents and their use in selected diseases from recent literature. Schattauer GmbH.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29727898     DOI: 10.15654/TPK-180274

Source DB:  PubMed          Journal:  Tierarztl Prax Ausg K Kleintiere Heimtiere        ISSN: 1434-1239            Impact factor:   0.596


  4 in total

1.  Evaluating the use of cytosine arabinoside for treatment for recurrent canine steroid-responsive meningitis-arteritis.

Authors:  Christian Günther; Frank Steffen; Daniela S Alder; Laura Beatrice; Caroline Geigy; Katrin Beckmann
Journal:  Vet Rec       Date:  2020-02-21       Impact factor: 2.695

Review 2.  Vaccination of Immunocompromised Cats.

Authors:  Katrin Hartmann; Karin Möstl; Albert Lloret; Etienne Thiry; Diane D Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Regina Hofmann-Lehmann; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Séverine Tasker; Uwe Truyen; Margaret J Hosie
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

3.  Evaluating the use of cytosine arabinoside for treatment for recurrent canine steroid-responsive meningitis-arteritis.

Authors:  Christian Günther; Frank Steffen; Daniela S Alder; Laura Beatrice; Caroline Geigy; Katrin Beckmann
Journal:  Vet Rec       Date:  2020-07       Impact factor: 2.695

Review 4.  Immunomodulatory and immunosuppressive drug protocols in the treatment of canine primary immune thrombocytopenia, a scoping review.

Authors:  Peter Spanner Kristiansen; Lise Nikolic Nielsen
Journal:  Acta Vet Scand       Date:  2021-12-27       Impact factor: 1.695

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.